Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations (Q33379346)

26 July 2017

Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations (English)

1 reference

atypical hemolytic uremic syndrome

26 July 2017

1 reference

Véronique Frémeaux-Bacchi

inferred from title

author

6

object named as

Véronique Frémeaux-Bacchi

1 reference

26 July 2017

7

Timothy H J Goodship

1 reference

26 July 2017

Anne-Laure Lapeyraque

1

1 reference

26 July 2017

Eric Wagner

2

1 reference

26 July 2017

Véronique Phan

3

1 reference

26 July 2017

Marie-José Clermont

4

1 reference

26 July 2017

Aïcha Merouani

5

1 reference

26 July 2017

Pierre Robitaille

8

1 reference

26 July 2017

19 April 2008

1 reference

26 July 2017

1 reference

26 July 2017

23

1 reference

26 July 2017

8

1 reference

26 July 2017

1363-1366

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-008-0803-4

26 July 2017

0 references

cites work

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome

1 reference

12 December 2020

Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome

1 reference

12 December 2020

Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation

1 reference

12 December 2020

Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation

1 reference

12 December 2020

Attempted treatment of factor H deficiency by liver transplantation

1 reference

12 December 2020

Genetic studies into inherited and sporadic hemolytic uremic syndrome

1 reference

12 December 2020

Familial hemolytic uremic syndrome associated with complement factor H deficiency

1 reference

12 December 2020

Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment

1 reference

12 December 2020

De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome

1 reference

12 December 2020

The human complement factor H: functional roles, genetic variations and disease associations

1 reference

12 December 2020

Atypical haemolytic uraemic syndrome and mutations in complement regulator genes

1 reference

12 December 2020

Familial haemolytic uraemic syndrome and an MCP mutation

1 reference

12 December 2020

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

1 reference

12 December 2020

The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

1 reference

12 December 2020

Combined kidney and liver transplantation for familial haemolytic uraemic syndrome

1 reference

12 December 2020

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

1 reference

12 December 2020

Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency.

1 reference

12 December 2020

Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.

1 reference

12 December 2020

The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children

1 reference

12 December 2020

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

1 reference

12 December 2020

Challenges in the management of infantile factor H associated hemolytic uremic syndrome.

1 reference

12 December 2020

Secondary failure of plasma therapy in factor H deficiency

1 reference

12 December 2020

An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations

1 reference

12 December 2020

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

1 reference

12 December 2020

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

1 reference

12 December 2020

Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

1 reference

12 December 2020

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition

1 reference

12 December 2020

10.1007/S00467-008-0803-4

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference